The efficacy of intravitreal triamcinolone acetonide on macular edema in branch retinal vein occlusion

European Journal of Ophthalmology

Volumn 15, Issue 1, 2005, Pages 96-101

  Özkiriş, Abdullah ^a,b   Evereklioglu, C ^a   Erkilic K ^a   Ilhan, O ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

^b Yildirim Beyazit Mah Mustafa Simsek   (Turkey)

Author keywords

Branch retinal vein occlusion; Intravitreal triamcinolone injection; Laser treatment; Macular edema

Indexed keywords

ANTIGLAUCOMA AGENT; KENOCORT; TRIAMCINOLONE ACETONIDE; GLUCOCORTICOID;

ADULT; AGED; ALGORITHM; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR HYPERTENSION; MALE; PRIORITY JOURNAL; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TOMOGRAPHY; TREATMENT OUTCOME; VISUAL ACUITY; FLUORESCENCE ANGIOGRAPHY; INJECTION; INTRAOCULAR PRESSURE; MIDDLE AGED; RETINA MACULA CYSTOID EDEMA; VITREOUS BODY;

AGED; FEMALE; FLUORESCEIN ANGIOGRAPHY; GLUCOCORTICOIDS; HUMANS; INJECTIONS; INTRAOCULAR PRESSURE; MACULAR EDEMA, CYSTOID; MALE; MIDDLE AGED; RETINAL VEIN OCCLUSION; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITREOUS BODY;

EID: 12344250615     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210501500115     Document Type: Article

References (27)

1. Jalkh AE, Trempe CL. Macular edema in branch retinal vein occlusion: types and treatment. Ophthalmic Surg 1989; 20: 26-32.
2. Bhagat N, Von Hagen S, Zarbin MA. Perimetric sensitivity and retinal thickness in eyes with macular edema resulting from branch retinal vein occlusion. Am J Ophthalmol 2002; 133: 428-9.
3. Michels RG, Gass JDM. The natural course of retinal branch vein obstruction. Trans Am Acad Ophthalmol Otolaryngol 1974; 78: 166-77.
4. Gutman FA, Zegarra H. The natural course of temporal retinal branch vein occlusion. Trans Am Acad Ophthalmol Otolaryngol 1974; 78: 178-92.
5. Finkelstein D. Ischemic macular edema: recognition and favorable natural history in branch vein occlusion. Arch Ophthalmol 1992; 110: 1427-34.
6. Dick JSB, Jampol LM, Haller JA. Macular edema. In: Ryan SJ, ed. Retina. 3rd ed. Philadelphia: Mosby; 2001: 967-81.
7. The Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 1984; 98: 271-82.
8. Ozerdem U, Freeman WR. Exudative retinal detachment following grid laser photocoagulation in a patient with hemiretinal vein occlusion. Eur J Ophthalmol 2001; 11: 89-92.
9. Han DP, Mieler WF, Burton TC. Submacular fibrosis after photocoagulation for diabetic macular edema. Am J Ophthalmol 1992; 113: 513-21.
10. Lewis H, Schachat AP, Haimann MH, et al. Choroidal neovascularization after laser photocoagulation for diabetic macular edema. Ophthalmology 1990; 97: 503-10.
11. Kivilcim M, Peyman GA, El-Dessouky ES, Kazi AA, Cheema R, Hegazy H. Retinal toxicity of triamcinolone acetonide in silicone-filled eyes. Ophthalmic Surg Lasers 2000; 31: 474-8.
12. McCuen BW, Bessler M, Tano Y, Chandler D, Machemer R. The lack of toxicity of intravitreally administered triamcinolone acetonide. Am J Ophthalmol 1981; 91: 785-8.
13. Wilson CA, Berkowitz BA, Sato Y, Ando N, Handa JT, de Juan E Jr. Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol 1992; 110: 1155-9.
14. Zambarakji HJ, Evans JE, Amoaku WM, Vernon SA. Reproducibility of volumetric measurements of normal maculae with the Heidelberg retina tomograph. Br J Ophthalmol 1998; 82: 884-91.
15. McAllister IL, Douglas JP, Constable IJ, Yu DY. Laser-induced chorioretinal venous anastomosis for nonischemic central retinal vein occlusion: evaluation of the complications and their risk factors. Am J Ophthalmol 1998; 126: 219-29.
16. Aktan SG, Subasi M, Akbatur H, Or M. Problems of chorioretinal venous anastomosis by laser for treatment of nonischemic central retinal vein occlusion. Ophthalmologica 1998; 212: 389-93.
17. Mester U, Dillinger P. Vitrectomy with arteriovenous decompression and internal limiting membrane dissection in branch retinal vein occlusion. Retina 2002; 22: 740-6.
18. Scott IU. Vitreoretinal surgery for complications of branch retinal vein occlusion. Curr Opin Ophthalmol 2002; 13: 161-6.
19. Le Rouic JF, Bejjani RA, Rumen F, et al. Adventitial sheathotomy for decompression of recent onset branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2001; 239; 747-51.
20. Glacet-Bernard A, Kuhn D, Vine AK, Oubraham H, Coscas G, Soubrane G. Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study. Br J Ophthalmol 2000; 84: 609-13.
21. Chandler DB, Hida T, Sheta S, Proia AD, Machemer R. Improvement in efficacy of corticosteroid therapy in an animal model of proliferative vitreoretinopathy by pre-treatment. Graefes Arch Clin Exp Ophthalmol 1987; 225: 259-65.
22. Kompella UB, Bandi N, Ayalasomayajula SP. Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression. Invest Ophthalmol Vis Sci 2003; 44: 1192-201.
23. Scholes GN, O'Brien WJ, Abrams GW, Kubicek MF. Clearance of triamcinolone from vitreous. Arch Ophthalmol 1985; 103: 1567-9.
24. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2002; 240: 782-3.
25. Bynoe LA, Weiss JN. Retinal endovascular surgery and intravitreal triamcinolone acetonide for central vein occlusion in young adults. Am J Ophthalmol 2003; 135: 382-4.
26. Greenberg PB, Martidis A, Rogers AH, Duker JS, Reichel E. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 2002; 86: 247-8.
27. Ip MS, Kumar KS. Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion. Arch Ophthalmol 2002; 120: 1217-9.